PT840620E - Antagonistas de il-8 para o tratamento de asma - Google Patents

Antagonistas de il-8 para o tratamento de asma

Info

Publication number: PT840620E
Authority: PT; Portugal
Prior art keywords: antagonists; asthma treatment; asthma; treatment; methods
Prior art date: 1995-06-27

Application number

PT96921804T

Other languages

English (en)

Inventor

Caroline A Hebert

Rhona C Kabakoff

Mark W Moore

Original Assignee

Genentech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-27

Filing date

1996-06-26

Publication date

2002-04-29

1996-06-26 Application filed by Genentech Inc filed Critical Genentech Inc

2002-04-29 Publication of PT840620E publication Critical patent/PT840620E/pt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

PT96921804T 1995-06-27 1996-06-26 Antagonistas de il-8 para o tratamento de asma PT840620E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US08/491,334 US5874080A (en)	1994-03-03	1995-06-27	Anti-IL-8 monoclonal antibodies for treatment of asthma

Publications (1)

Publication Number	Publication Date
PT840620E true PT840620E (pt)	2002-04-29

Family

ID=23951745

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT96921804T PT840620E (pt)	1995-06-27	1996-06-26	Antagonistas de il-8 para o tratamento de asma

Country Status (12)

Country	Link
US (1)	US5874080A (pt)
EP (1)	EP0840620B1 (pt)
JP (1)	JPH11509840A (pt)
AT (1)	ATE206621T1 (pt)
AU (1)	AU727343C (pt)
CA (1)	CA2222024A1 (pt)
DE (1)	DE69615843T2 (pt)
DK (1)	DK0840620T3 (pt)
ES (1)	ES2165506T3 (pt)
NZ (1)	NZ311561A (pt)
PT (1)	PT840620E (pt)
WO (1)	WO1997001354A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996002576A1 (fr) *	1994-07-13	1996-02-01	Chugai Seiyaku Kabushiki Kaisha	Anticorps humain reconstitue contre l'interleukine-8 humaine
US7122636B1 (en) *	1997-02-21	2006-10-17	Genentech, Inc.	Antibody fragment-polymer conjugates and uses of same
DE69821338T2 (de) *	1997-02-21	2004-10-21	Genentech Inc	Antikörperfragment-polymerkonjugate
US6458355B1 (en)	1998-01-22	2002-10-01	Genentech, Inc.	Methods of treating inflammatory disease with anti-IL-8 antibody fragment-polymer conjugates
US6468532B1 (en)	1998-01-22	2002-10-22	Genentech, Inc.	Methods of treating inflammatory diseases with anti-IL-8 antibody fragment-polymer conjugates
WO1999065310A1 (en) *	1998-06-17	1999-12-23	Smithkline Beecham Corporation	Il-8 receptor antagonists
US20080038274A1 (en) *	1999-09-23	2008-02-14	Foster Keith A	Inhibition of secretion from non-neuronal cells
US6753135B2 (en) *	2000-09-20	2004-06-22	Surromed, Inc.	Biological markers for evaluating therapeutic treatment of inflammatory and autoimmune disorders
AU2003220439A1 (en) *	2002-03-19	2003-10-08	Abgenix, Inc.	Methods for treating chronic obstructive pulmonary disease (copd)
NZ540767A (en) *	2002-11-27	2009-03-31	Dmi Biosciences Inc	Treatment of diseases and conditions mediated by increased phosphorylation
WO2004058797A2 (en)	2002-12-16	2004-07-15	Medarex, Inc.	Human monoclonal antibodies against interleukin 8 (il-8)
MX2007013058A (es) *	2005-04-20	2008-02-22	Amgen Fremont Inc	Anticuerpos monoclonales de alta afinidad completamente humanos para interleucina-8 y epitopes para dichos anticuerpos.
AU2019207812A1 (en)	2018-01-12	2020-07-23	Bristol-Myers Squibb Company	Combination therapy with anti-IL-8 antibodies and anti-PD-1 antibodies for treating cancer
WO2023192478A1 (en)	2022-04-01	2023-10-05	Bristol-Myers Squibb Company	Combination therapy with anti-il-8 antibodies and anti-pd-1 antibodies for treating cancer

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4816567A (en) *	1983-04-08	1989-03-28	Genentech, Inc.	Recombinant immunoglobin preparations
US5229275A (en) *	1990-04-26	1993-07-20	Akzo N.V.	In-vitro method for producing antigen-specific human monoclonal antibodies
PT98072B (pt) *	1990-06-22	1998-11-30	Chiron Corp	Processo para a preparacao de polipeptidos contendo proteina macrofagica inflamatoria humana mip-2 alfa por metodos recombinantes e de composicoes farmaceuticas que os contem
US5234911A (en) *	1990-07-09	1993-08-10	Gist-Brocades, N.V.	Substance with interleukin-8 inhibiting activity and process for its preparation
IE913192A1 (en) *	1990-09-12	1992-02-25	Scripps Research Inst	Active site of interleukin-8: polypeptide analogs and¹antibodies
EP0909817A1 (en) *	1990-09-28	1999-04-21	Chiron Corporation	Uses of gro genes and proteins
WO1992006697A1 (en) *	1990-10-23	1992-04-30	Repligen Corporation	Anti-inflammatory composition
WO1992008474A2 (en) *	1990-11-20	1992-05-29	The National Heart & Lung Institute	Treatment of lung diseases
JPH0597A (ja) *	1991-06-21	1993-01-08	Snow Brand Milk Prod Co Ltd	新規抗ｔｃｆ−ｉｉモノクローナル抗体及びそれを用いるｔｃｆ−ｉｉの測定方法
AU2348492A (en) *	1991-07-19	1993-02-23	East Carolina University	Method of treating asthma
WO1994004173A1 (en) *	1992-08-21	1994-03-03	The Scripps Research Institute	Therapeutic compositions and methods for inhibiting il-8-mediated inflammation
WO1995023865A1 (en) *	1994-03-03	1995-09-08	Genentech, Inc.	Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders

1995
- 1995-06-27 US US08/491,334 patent/US5874080A/en not_active Expired - Fee Related
1996
- 1996-06-26 WO PCT/US1996/011033 patent/WO1997001354A1/en active IP Right Grant
- 1996-06-26 NZ NZ311561A patent/NZ311561A/en unknown
- 1996-06-26 AU AU62924/96A patent/AU727343C/en not_active Ceased
- 1996-06-26 PT PT96921804T patent/PT840620E/pt unknown
- 1996-06-26 DE DE69615843T patent/DE69615843T2/de not_active Expired - Fee Related
- 1996-06-26 DK DK96921804T patent/DK0840620T3/da active
- 1996-06-26 JP JP9504031A patent/JPH11509840A/ja not_active Ceased
- 1996-06-26 CA CA002222024A patent/CA2222024A1/en not_active Abandoned
- 1996-06-26 EP EP96921804A patent/EP0840620B1/en not_active Expired - Lifetime
- 1996-06-26 AT AT96921804T patent/ATE206621T1/de not_active IP Right Cessation
- 1996-06-26 ES ES96921804T patent/ES2165506T3/es not_active Expired - Lifetime

Also Published As

Publication number	Publication date
AU727343C (en)	2002-01-03
DE69615843D1 (de)	2001-11-15
AU727343B2 (en)	2000-12-14
EP0840620A1 (en)	1998-05-13
DE69615843T2 (de)	2002-05-16
US5874080A (en)	1999-02-23
JPH11509840A (ja)	1999-08-31
EP0840620B1 (en)	2001-10-10
AU6292496A (en)	1997-01-30
NZ311561A (en)	1999-10-28
ATE206621T1 (de)	2001-10-15
DK0840620T3 (da)	2002-02-04
ES2165506T3 (es)	2002-03-16
WO1997001354A1 (en)	1997-01-16
CA2222024A1 (en)	1997-01-16

Publication	Publication Date	Title
DK1516629T3 (da)	2013-06-03	Humaniseret anti-CD-11a antibodies
ATE255906T1 (de)	2003-12-15	Antikörper gegen cd40
PT719859E (pt)	2003-11-28	Anticorpo monoclonal anti-alfa v-integrina
CY2005008I2 (el)	2017-11-14	Αντισωματα αντι - vegf
IS4892A (is)	1998-11-10	Styrkt mótefnisblanda
DE69509975T2 (de)	2000-01-20	Ferritträger für elektrophotographische Entwickler, und Entwickler die Träger enthaltend
PT941121E (pt)	2005-01-31	Preparados farmaceuticos liofilizados, estaveis, de anticorpos monoclonais ou policlonais
PT840620E (pt)	2002-04-29	Antagonistas de il-8 para o tratamento de asma
DE3854502D1 (de)	1995-10-26	Gegen hiv-antigene spezifischer monoklonaler antikörper.
DE69828154D1 (de)	2005-01-20	Anti-alphavbeta3 humanizierte monoklonale antikörper
DE69738312D1 (de)	2008-01-03	Hepatitis b monoklonale antikörper
DK0709455T3 (da)	1999-02-22	Monoklonalt antistof med humanglicentin, hybridoma til fremstilling af antistoffet og assaymetode for humanglicentin ved an
TR199501542A2 (tr)	1996-07-21	Bagisiklik önleyici aktiviteye sahip monoklonal antikor parcalari.
NO20004251D0 (no)	2000-08-24	Humaniserte anti-CEA monoklonale antistoffer med høy affinitet
DE59611293D1 (de)	2005-12-15	Protein mit dnase-aktivität
NO890116L (no)	1989-07-13	Monoklonale antistoffer.
DE69020315T2 (de)	1996-01-11	Monoklonaler antikörper gegen c-reaktives protein.
DE68912772T2 (de)	1994-09-01	Monoklonaler antikörper gegen entero-viren.
DE69023717D1 (de)	1996-01-04	Monoklonaler Antikörper.
ATE263784T1 (de)	2004-04-15	Anti-megakaryozyten monoklonaler antikörper 97a6
DE69427850T2 (de)	2001-12-06	Monoklonaler antikörper gegen mucoglykoprotein
EA199800028A1 (ru)	1998-08-27	Винилсульфоксиды и способы их синтеза
SE9404491D0 (sv)	1994-12-23	Process for the production of human monoclonal antibodies
DE69732636D1 (de)	2005-04-07	Monoklonaler antikörper gegen humanes mp52
BR1100555B1 (pt)	2009-01-13	anticorpos monoclonais humanizados.